Recursion Pharmaceuticals Inc Clas (RXRX)
EBITDA Margin
-1467.14%
Quarterly · Period ending:
RXRX EBITDA Margin
Latest reported-1467.14%period ending
Latest reported-1467.14%period ending
RXRX Quarterly EBITDA Margin (0.00% → -1467.14%)
Quarterly ebitda margin
High-resolution chart · PNG
RXRX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -1,467.1447% | |
| -1,577.3331% | |
| -249.3781% | |
| -2,728.6377% | |
| -772.486% | |
| -1,239.783% | |
| -3,665.3292% | |
| -337.1061% | |
| -615.8081% | |
| -628.2336% | |
| -842.2346% | |
| -845.5157% | |
| -645.9513% | |
| -507.4996% | |
| -396.79% | |
| -440.0751% | |
| -820.0706% | |
| -1,003.9253% | |
| -2,508.64% | |
| -1,790.88% | |
| -1,542.76% | |
| -1,162.64% | |
| -937.3187% | |
| -2,623.5499% | |
| 0% | |
| 0% |